Intra-articular Injection: A Innovational Approach for Joint Disorder

Impact of Intra-articular Injection on Temporomandibular Joint Disorder

The goal of this clinical trial is to study about the clinical effect of Intra-articular Injection on Temporomandibular Joint Dysfunction

The main question it aims to answer is:

• Can Intra-articular Injection help improve the Temporomandibular Joint Dysfunction Participants will be randomly assigned into the experimental group and the control group, all under comprehensive treatment. The experimental group will be given Intra-articular Injection additionally, The study lasts 15 days for each patient. Researchers will compare the assessments between the two groups to see if Intra-articular Injection can help improve the Temporomandibular Joint Dysfunction

The background of Temporomandibular Joint Dysfunction is that it is one of the common diseases in the oral and maxillofacial region, and it is the most common among temporomandibular joint diseases. It is more prevalent in young adults, with the highest prevalence rate at 20-30 years old.

The goal of this clinical trial is to study about the clinical effect of Intra-articular Injection on Temporomandibular Joint Dysfunction

The main question it aims to answer is:

• Can Intra-articular Injection help improve the Temporomandibular Joint Dysfunction Participants will be randomly assigned into the experimental group and the control group, all under comprehensive treatment. The experimental group will be given Intra-articular Injection additionally, The study lasts 15 days for each patient. Researchers will compare the assessments between the two groups to see if Intra-articular Injection can help improve the Temporomandibular Joint Dysfunction

Inclusion Criteria:

• Presence of significant temporomandibular disorder clinical symptoms.
• Meeting the diagnostic criteria for Temporomandibular Joint Dysfunction and confirmed by X-ray examination.
• Patients voluntarily participate in this study and provide signed informed consent.
• Normal cognitive function

Exclusion Criteria:

• Rheumatic, rheumatoid, or other severe systemic diseases.
• Infectious temporomandibular joint arthritis or joint tumors.
• Individuals who have recently received joint injection treatment or photodynamic therapy.